| 000 | 04472naa a22005417i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-PH-059 | ||
| 003 | local | ||
| 005 | 20261005174916.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2018 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.3748/wjg.v24.i43.4846 _2doi |
|
| 035 | _a(local)EuropePMC:PMC6250924 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aAndrew McGuigan _eauthor. |
|
| 245 | 1 | 0 |
_aPancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. / _cAndrew McGuigan; Paul Kelly; Richard C Turkington [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bBaishideng Publishing Group Inc, _c2018. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aThis review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further research in this understudied malignancy. Pancreatic adenocarcinoma is a lethal condition with a rising incidence, predicted to become the second leading cause of cancer death in some regions. It often presents at an advanced stage, which contributes to poor five-year survival rates of 2%-9%, ranking firmly last amongst all cancer sites in terms of prognostic outcomes for patients. Better understanding of the risk factors and symptoms associated with this disease is essential to inform both health professionals and the general population of potential preventive and/or early detection measures. The identification of high-risk patients who could benefit from screening to detect pre-malignant conditions such as pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasms and mucinous cystic neoplasms is urgently required, however an acceptable screening test has yet to be identified. The management of pancreatic adenocarcinoma is evolving, with the introduction of new surgical techniques and medical therapies such as laparoscopic techniques and neo-adjuvant chemoradiotherapy, however this has only led to modest improvements in outcomes. The identification of novel biomarkers is desirable to move towards a precision medicine era, where pancreatic cancer therapy can be tailored to the individual patient, while unnecessary treatments that have negative consequences on quality of life could be prevented for others. Research efforts must also focus on the development of new agents and delivery systems. Overall, considerable progress is required to reduce the burden associated with pancreatic cancer. Recent, renewed efforts to fund large consortia and research into pancreatic adenocarcinoma are welcomed, but further streams will be necessary to facilitate the momentum needed to bring breakthroughs seen for other cancer sites. | |
| 540 |
_aCreative Commons Attribution-NonCommercial (licence family recorded by the source; version not supplied in metadata). _uhttps://europepmc.org/articles/PMC6250924 |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Public Health. | ||
| 650 | 4 | _aPancreatic cancer | |
| 650 | 4 | _aPancreatic adenocarcinoma | |
| 650 | 4 | _aPancreatic Cancer Treatment | |
| 650 | 4 | _aPancreatic Cancer Risk Factors | |
| 653 | _aB. Sc. Public Health | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aepidemiology | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aPaul Kelly _eauthor. |
|
| 700 | 0 |
_aRichard C Turkington _eauthor. |
|
| 700 | 0 |
_aClaire Jones _eauthor. |
|
| 700 | 0 |
_aHelen G Coleman _eauthor. |
|
| 700 | 0 |
_aR Stephen McCain _eauthor. |
|
| 773 | 0 |
_tWorld journal of gastroenterology _gVol. 24, no. 43, (2018), pages/article 4846-4861 _x1007-9327 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC6250924 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC6250924 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1331 _d1331 |
||